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Abstract 
Background: Helicobacter pylori, colonize in stomach of ~50% of the world population. cag pathogenicity Island of H. 
pylori is one of the important virulent factors that attributed to gastric inflammation. Coinfection with H. pylori strain 
with different genetic makeup alters the degree of pathogenicity and susceptibility towards antibiotics. The present 
study investigates host immunomodulatory effects of H. pylori infection by both cag+ strain (SS1) and cag− strain 
(AM1). C57BL/6 mice were infected with AM1 or SS1 strain as well as AM1 followed by SS1 (AM1/SS1) and vice versa.
Results: Mice infected with AM1/SS1 strain exhibited less gastric inflammation and reduced proMMP9 and proMMP3 
activities in gastric tissues as compared to SS1/SS1 and SS1/AM1 infected groups. The expression of both MMP9 and 
MMP3 followed similar trend like activity in infected tissues. Both Th1 and Th17 responses were induced by SS1 strain 
more profoundly than AM1 strain infection which induced solely Th1 response in spleen and gastric tissues. Moreover, 
IFN-γ, TNF-α, IL-1β and IL-12 were significantly downregulated in mice spleen and gastric tissues infected by AM1/SS1 
compared to SS1/SS1 but not with SS1/AM1 coinfection. Surprisingly, IL-17 level was dampened significantly in AM1/
SS1 compared to SS1/AM1 coinfected groups. Furthermore, number of Foxp3+ T-regulatory (Treg) cells and immuno-
suppressive cytokines like IL-10 and TGF-β were reduced in AM1/SS1 compared to SS1/SS1 and SS1/AM1 coinfected 
mice gastric tissues.
Conclusions: These data suggested that prior H. pylori cag− strain infection attenuated the severity of gastric pathol-
ogy induced by subsequent cag+ strain in C57BL/6 mice. Prior AM1 infection induced Th1 cytokine IFN-γ, which 
reduced the Th17 response induced by subsequent SS1 infection. The reduced gastritis in AM1/SS1-infected mice 
might also be due to enrichment of AM1- primed Treg cells in the gastric compartment which inhibit Th1 and Th17 
responses to subsequent SS1 infection. In summary, prior infection by non-virulent H. pylori strain (AM1) causes reduc-
tion of subsequent virulent strain (SS1) infection by regulation of inflammatory cytokines and MMPs expression.
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Background
Helicobacter pylori, a class I carcinogen inhabit in the 
stomach of approximately 50% of the human popu-
lation while only 10–15% population either develop 
chronic gastritis or gastric adenocarcinoma or gastric 
mucosa-associated lymphoid tissue lymphoma [1–4]. The 
underlying mechanisms governing the clinical outcome 
of H. pylori infection are poorly understood. However, 
accumulated evidences suggested that differences in host 
immune responses, environmental factors as well as the 
virulence properties of H. pylori strains may play impor-
tant roles in determining the disease outcome. The most 
prominent H. pylori virulence-associated determinant is 
the cag pathogenicity island (PAI). It is a 40-kb genome 
segment that encodes the immunodominant protein 
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cagA and type IV secretion system, which serve to trans-
fer the bacterial cagA protein and other soluble factors 
such as peptidoglycans, to the cytoplasm of the host 
cells, known to play a key role in disease manifestation 
[5–7]. Strains harboring the cag PAI have been associ-
ated with more severe inflammatory responses than that 
induced by cag− strains [6, 8, 9]. H. pylori specific host T 
cell response is predominantly a CD4+  T cell response 
polarized towards a T helper1 (Th1) phenotype [10, 11]. 
H. pylori induced inflammation are associated with the 
production of pro-inflammatory cytokines and appear to 
be triggered partly by genes located within the cag PAI [6, 
8, 12]. The gastric mucosal levels of the proinflammatory 
cytokine IL-1β, IL-6, IL-8 and TNF-α were increased in 
H. pylori infected subjects [13]. Earlier studies revealed 
that H. pylori infection is also associated with a marked 
increased in cytokine IL-17 secretion from Th17 cells 
[14]. Involvement of IL-17 has also been reported in vari-
ous other chronic inflammatory conditions such as rheu-
matoid arthritis and multiple sclerosis [15, 16]. Recently, 
Shi et  al. suggested that H. pylori infection induced a 
mixed Th1/Th17 response [17]. In addition, cagA and 
type IV secretion system are required for the induction 
of IL-17 responses in H. pylori infection [18]. Secretion of 
IL-17 led to induction of other inflammatory molecules 
required for the establishment of chronic inflammation 
[19].
MMPs are a family of zinc dependent endopeptidases 
that play a crucial role in various pathological conditions 
including gastric ulcer [20–22]. The activities of MMPs 
are regulated by their inhibitors (TIMPs), while their 
expressions are modulated by cytokines, growth fac-
tors, tumor promoters and transcription factors [20, 23, 
24]. Gelatinases B (MMP9) and stromelysin-1 (MMP3) 
are the two major inflammatory contributors of gas-
tric pathology, collectively cleave a large array of matrix 
proteins [25]. Accumulated evidences suggested that H. 
pylori induced gastric inflammation with the upregula-
tion of MMP9 and MMP3 in vivo [26]. MMPs are either 
directly or indirectly produced by gastric epithelial cells 
via cytokine mediated cell signaling pathways [24].
The gastrointestinal tract of human are colonized by 
various microorganisms which can be either commensal-
istic or pathogenic to human [27]. The interplay among 
those organisms can lead to either attenuation or pro-
motion of infection-induced pathology. For instance, 
C57BL/6 mice coinfection with a natural murine nema-
tode parasite Heligmosomoides polygyrus, attenuated 
gastric pathology induced by H. felis [28]. Attenuation of 
gastric pathology was associated with reduced expres-
sion of proinflammatory Th1 cytokine as well as with 
increased Th2 cytokine levels. Interaction between dif-
ferent bacterial species also determines diseases severity. 
Recently it has been documented that H. pylori infection 
attenuated Salmonella enterica serovar Typhimurium-
induced colitis in C57BL/6 mice; this protective effect 
was associated with downregulation of the cecal Th17 
response to S. typhimurium [29]. Even severity of the 
H. pylori induced gastric pathology is also modulated 
by coinfection with other Helicobacter species. Coinfec-
tion of enterohepatic Helicobacter species (EHS), Heli-
cobacter muridarum along with H. pylori attenuated the 
H. pylori induced gastric pathology in C57BL/6 mice 
[30]. Moreover, coinfection of another EHS, Helicobac-
ter hepaticus with H. pylori lead to more severe gastritis 
as well as increased production of IL-17 cytokine [30]. 
Interestingly, it has also been reported that the interac-
tions between different strains of H. pylori also modulate 
gastric inflammation status [31].
Surprisingly, in some African countries having lower 
economic status show high rate of H. pylori infection but 
low level of gastric carcinoma incidence, widely known 
as African Enigma [32, 33]. The reasons could be asso-
ciated with diet, infection with other endemic parasites 
and degree of pathogenicity of different H. pylori strains. 
We hypothesized that coinfection with a non pathogenic 
strain may provide protection against further infection 
of a virulent strain. The effect of coinfection on gastric 
inflammation, with different strains of H. pylori with or 
without cag Pathogenicity Island, has not been system-
atically studied yet. To investigate that, we established a 
coinfection in C57BL/6 mice using both cag− and cag+ 
strains of H. pylori and measured the gastric inflamma-
tory pathways. We address whether prior cag− strain 
infection alleviate gastric damage induced by cag+ H. 
pylori strain coinfection and the underlying host immu-
nomodulatory mechanisms thereon. Here we for the first 
time documents that prior infection with cag− H. pylori 
strain dampens the disease severity for further cag+ 
coinfection.
Results
Prior cag− H. pylori infection dampens gastric inflammation 
due to cag+ H. pylori infection
We previously reported that both cag+ strains (SS1) 
and cag− strain (AM1) has the capacity to induce gas-
tric inflammation, although the severity of damage was 
more pronounced in SS1 infection in C57BL/6 mice [26]. 
In present study, we investigated the coinfection of dif-
ferent strains of H. pylori in different combination on 
disease burden of H. pylori induced gastric pathology in 
C57BL/6 mice. Different groups of mice were inoculated 
with vehicle for control, SS1 and boosted with SS1 strain, 
inoculated with AM1 boosted with AM1 strain, SS1 and 
boosted with AM1 strain and AM1 and boosted with 
SS1 strain of H. pylori separately and were sacrificed at 
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day 10 post infection. Histological examination of mouse 
gastric tissues revealed that H. pylori infection in any 
combination of strains caused inflammation in gastric 
pit cells along with disruption in submucosa and mus-
cularis mucosa compared with control (Fig. 1). Glandu-
lar atrophy and infiltration of inflammatory cells, mostly 
lymphocytes, were also detected in the gastric tissues of 
all infected mice groups. However, mice inoculated with 
AM1 followed by SS1 strain exhibited significantly lower 
level of gastric inflammation, glandular atrophy, surface 
epithelial eruption and decreased infiltration of inflam-
matory cells compared to SS1/SS1 infected and SS1/
AM1 coinfected mice. However, no significant differ-
ence in the gastric lesions in AM1/AM1 and AM1/SS1 
coinfected mice were detected (Fig.  1b, e). Therefore, 
these results suggested that earlier cag− H. pylori strain 
infection significantly abrogated the severity of gastric 
inflammation induced by further H. pylori cag+ strain 
infection.
The activity and expression of MMP9 and 3 were 
upregulated with increased severity of gastric lesion
Aberrant ECM remodeling is a prerequisite event in gas-
tric ulcer development. MMP2 and 9 are the two most 
potent enzymes involved in the ECM remodeling. Hence, 
we measured and compared the activity and expression 
of MMP2 and 9 by gelatin zymography and Western blot-
ting respectively in H. pylori infected mice gastric tissue 
extracts. We found that there is a significant upregulation 
of MMP9 activity and expression in H. pylori infected 
gastric tissues compared with control (Fig. 2a–c). Highest 
level of activity and expression of MMP9 were obtained 
in SS1/SS1 infected gastric tissues. However, interest-
ingly AM1/SS1 coinfected mice showed decreased level 
of MMP9 expression and activity compared to SS1/
SS1 infected and SS1/AM1 coinfected gastric tissues. 
In between coinfected groups, MMP9 expression and 
activity were detected higher in SS1/AM1 in compared 
to AM1/SS1 coinfected group. We also measured the 
Fig. 1 Histology of mouse gastric tissues infected with H. pylori. Different groups of mice were intragastrically inoculated with SS1 (cag+) and AM1 
(cag−) strains alone or coinfected with both strains of H. pylori (SS1 followed by AM1, AM1 followed by SS1). Control mice were fed with PBS and 
kept separately under the same conditions. Mice were sacrificed and gastric tissue sections were processed for histological analysis. Histologi-
cal appearances of control (A1), AM1/AM1 infected (B1), SS1/SS1 infected (C1), SS1/AM1-coinfected (D1), AM1/SS1-coinfected (E1) gastric tissues 
stained with hematoxylin and eosin and were observed at 10× magnification. While A2, B2, C2, D2 and E2 represent 20× magnification and A3, B3, 
C3, D3 and E3 represent 40× magnification of control, AM1/AM1, SS1/SS1, SS1/AM1, AM1/SS1-infected tissues. Gastric mucosal epithelium and 
inflammatory cells are shown by black arrows and green arrows, respectively
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activity and expression of another potent ECM degrad-
ing enzyme MMP3 in H. pylori infected and control mice 
gastric tissues. Like MMP9 similar trends of activity and 
expression pattern of MMP3 were detected (Fig.  2d–f). 
Highest level of MMP3 activity and expression were 
detected in SS1 infected group. Notably, lower level of 
MMP3 expression and activity were also detected in 
AM1/SS1 coinfected group.
To examine the effect of H. pylori infection on sys-
temic level of MMP9 and 2, we measured the activity of 
MMP9 in infected mice serum. Figure  3 shows that H. 
pylori infection also increases activity of proMMP9 in 
mice serum. In addition, AM1/SS1 coinfected mice show 
decreased level of serum MMP9 activity compared to SS1 
infected and SS1/AM1 coinfected groups.
Cytokine expression pattern differed in different 
combination of H. pylori infection
Th1 and Th17 cell response plays an important role to 
mediate inflammation during H. pylori induced gastric 
pathogenesis. Hence, we measured the level of proin-
flammatory cytokines IFN-γ and IL-17A in H. pylori 
infected mice gastric tissues using ELISA. All mice 
infected or coinfected with different H. pylori strains sig-
nificantly upregulated gastric IFN-γ compared to control 
(Fig. 4a) SS1/SS1 infected group secreted highest level of 
IFN-γ compared to any other groups. In addition, cag+ H. 
pylori infection irrespective of sequence of infection sig-
nificantly induced gastric IFN-γ secretion compared cag− 
H. pylori infection. Even though AM1/SS1 infected mice 
developed less severe gastric pathology than SS1/AM1, 
no significant differences in the level of IFN-γ secretion 
Fig. 2 Effect of H. pylori infection and coinfection on activity and expression of MMPs. Different strains of H. pylori (AM1 or SS1) were orally fed sepa-
rately or coinfected (AM1/SS1or SS1/AM1) to four groups of mice and they were sacrificed on day 10 post infection. Control mice were fed with PBS 
and kept separately under same conditions. The activities of MMP2 and 9 in mouse gastric tissue extracts were measured by gelatin zymography 
(a). Histographic representations of gelatinolytic activities as measured by lab image densitometry (b). Values were from the above zymograms and 
three other zymograms from independent experiments. Expression of MMP9 was measured by Western blotting analysis (c). Equal amount of tissue 
extracts (120 μg) of control and infected mice were used and probed with polyclonal anti-MMP9 and monoclonal anti-β actin antibody. The activity 
and expression of MMP3 in mouse gastric tissue extracts were measured by casein zymography and Western blot. Representative blots showing the 
activity and expression MMP3 (d, f). β-actin served as loading control. Histographic representations of MMP3 activity and expressions in control and 
H. pylori infected gastric tissues (e) from the above blots and two other representative blots from independent experiments in each case. Error bars 
±SEM ***P < 0.001; **P < 0.01; *P < 0.05; NS, P = not significant versus control
Page 5 of 13Ghosh et al. Gut Pathog  (2017) 9:14 
were detected. This observation led us to ask the question 
whether reduce gastric pathology in AM1/SS1 coinfected 
mice are due to reduce activation of Th17 response. We 
found that all mice that were prior infected with cag+ H. 
pylori significantly expressed higher level of gastric IL-
17A cytokine compared to control (Fig. 4a). However, no 
significant levels of IL-17A were detected in AM1/AM1 
infected or AM1/SS1 coinfected groups. Hence severe 
gastric damage in cag+ infection might be mediated by 
activation of IL-17 response.
To correlate the Th1 and Th17 cytokines responses in 
both gastric mucosa and spleen, the splenocytes from the 
infected mice were stimulated by H. pylori WCP in vitro 
for 48 h. Then, IFN-γ and IL-17A expression level in the 
supernatants of the cultured splenocytes were measured. 
Cytokines expression pattern in splenocytes match paral-
lel with gastric tissues in H. pylori infected mice (Fig. 4b).
To confirm the involvement of Th1 response in H. 
pylori infection, we further measured the cytokine 
IL-12 that is responsible for the regulation of Th1 cell 
response. Our result showed that prior SS1 infection 
significantly upregulated IL-12 secretion as compared 
to cag− H. pylori infection both in gastric mucosa and 
spleen (Fig. 4a, b). Highest level of IL-12 was detected in 
SS1/SS1 infected group while AM1/AM1 exhibited low-
est level. No significant difference in the expression of 
IL-12 was observed in between SS1/AM1 and AM1/SS1 
infected groups.
Immunosuppression is mediated by cytokines IL-10 
and TGF-β. Hence, we measured the level of IL-10 and 
TGF-β in H. pylori infected mouse gastric tissues. A sig-
nificant decrease in the level of IL-10 and TGF-β were 
observed in the AM1/SS1 coinfected mice which corre-
late with reduced gastric inflammation (Fig. 4c).
Infiltration of Foxp3+ Treg cells in cag+ strain infected 
gastric tissue was reduced by earlier cag− H. pylori 
infection
Foxp3 transcription factor is essential for differential 
development of anti inflammatory Treg cells. Increased 
numbers of CD4 CD25 Foxp3 regulatory T (Treg) cells 
were detected in H. pylori infected gastric tissues. To 
understand the immunosuppressive action of Treg cells 
during H. pylori infection or coinfection mediated gas-
tric pathogenesis, we measured the number of Treg cells 
present in all H. pylori infected and coinfected gastric tis-
sues. All groups infected with H. pylori showed elevated 
numbers of gastric Foxp3+ cells than control (Fig. 5a, b). 
Moreover prior cag+ H. pylori strain infected gastric tis-
sues exhibited higher number of Foxp3+ cells than cag− 
H. pylori. Although we did not found any significant 
differences in the gastric Foxp3+ Treg cells between SS1/
SS1 infected and SS1/AM1 coinfected mice and between 
AM1/AM1 infected and AM1/SS1 coinfected mice. In 
between the coinfected groups AM1/SS1 infected mice 
exhibited significantly lower gastric Foxp3+ cells than 
SS1/AM1 infected group. Interestingly decrease numbers 
of FoxP3+ Treg cells correlates with the low degree of 
gastric inflammation in AM1/SS1 infection. Hence, there 
is a positive association with number of foxp3+ Treg cells 
and gastric inflammation severity in H. pylori infection.
Interplay between inflammatory and immunosuppressive 
cytokines in H. pylori mediated gastric inflammation
Balance between inflammatory and immunosuppressive 
cytokines play important role in various chronic infec-
tions including H. pylori induced gastric injury. Inter-
play among Th1, Th17 and Treg cells and their signature 
cytokines are crucial for H. pylori induced pathogen-
esis. To understand the role of inflammatory (Th17 and 
Th1) and immunosuppressive (Treg) cytokines in H. 
pylori induced gastric pathology, we compared the level 
of various cytokines in mice gastric tissues infected or 
coinfected with different strains of H. pylori. We found 
Fig. 3 Serum MMP9 level reduced in AM1/SS1 coinfected mice. 
Different groups of mice were orally fed with either SS1 or AM1 
strains alone or coinfected with both strains of H. pylori (SS1 followed 
by AM1, AM1 followed by SS1). Control mice were fed with PBS and 
kept separately under the same conditions. Activity of MMP9 in mice 
serum was assayed by gelatin zymography (a). Equal volumes of 
serum were loaded in each lane for gelatin zymography. Histographic 
representation of gelatinolytic activity as measured by lab image 
densitometry (b). Data were represented as mean ± SD from three 
independent sets of experiment. Error bars ±SEM ***P < 0.001; 
*P < 0.05 NS, P = not significant versus control
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that H. pylori infection increased the expression of Th1 
cytokines, TNF-α and IL-1β in mice gastric tissues 
(Fig. 6). To check the contribution of cag PAI on immu-
nomodulation, we compared cytokine expression pattern 
among different combination of H. pylori infected mice 
gastric tissues. Our result suggested that Th1 cytokines, 
TNF-α and IL-1β expression increased in cag+ infection 
compared to cag− infection. SS1/SS1 infection exhibited 
highest level of TNF-α and IL-1β expression as com-
pared to other groups. Although, AM1/SS1 infected mice 
developed less gastric injury than SS1/AM1, no signifi-
cant difference in TNF-α and IL-1β cytokines level were 
observed in between these groups.
We also measured the expression of Th17 cytokine IL-
17A in different combination of H. pylori strain infected 
mice gastric tissues. Interestingly, we found that IL-17A 
expression increased in SS1/SS1 and SS1/AM1 infection, 
while no significant changes in IL-17A expression were 
observed in AM/AM1 infected group as compared to 
control. Surprisingly, AM1/SS1 infected group exhibited 
no significant increase in IL-17A expression as compared 
to control. We found a positive correlation between IL-
17A expression and severity of gastric inflammation. 
Expression pattern of immunosuppressive cytokine 
TGF-β was also measured using Western blotting. High-
est level of expression was detected in SS1/SS1 infected 
Fig. 4 Level of cytokines in mouse gastric tissues and supernatants from cultured splenocytes. Tissue homogenates of gastric tissue of different 
group of mice infected by different combination of H. pylori were subjected for analysis of IFN-γ, IL-12 and IL-17 production by ELISA (a). Results 
were expressed as pg/mg total protein. Splenocytes isolated from control and all H. pylori infected groups were re-stimulated with or without 
H. pylori WCP (2.5 mg/ml). Supernatants were collected 48 h after stimulation, and secreted cytokines were measured by ELISA (b). Results were 
expressed as pg/ml protein. Gastric tissues extract from controls and H. pylori infected mice were analyzed for immunosuppressive cytokines, IL-10 
and TGF-β production by ELISA (c). IL-10 and TGF-β concentration (pg/mg) were expressed as pg/mg total protein Error bars ±SEM ***P < 0.001; 
**P < 0.01; *P < 0.05; NS, P = not significant versus control; n = 4
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group. However, interestingly AM1/SS1 coinfected mice 
showed decreased TGF-β expression as compared to 
SS1/SS1 infected and SS1/AM1 coinfected groups. Fur-
thermore, we did not found any significant change in 
TGF-β expression between AM1/SS1 and AM1/AM1 
infected mice gastric tissues. The expression of TGF-β 
was higher in SS1/AM1 infected mice as compared to 
AM1/SS1 infected groups.
Discussion
Helicobacter pylori colonization and associated pathol-
ogy is determined by a combination of pathogen viru-
lence factors and host immune response [5, 6, 38]. H. 
pylori infection induced a robust proinflammatory 
Th1 and Th17 response that are associated with gas-
tric inflammation, atrophy, epithelial hyperplasia and 
dysplasia [10, 17, 18, 39]. Moreover, mixed or coinfec-
tion of different Helicobacter species/strains deter-
mined the outcome of disease severity. In this context, 
Secka et al. reported that mixed infection with cag+ and 
cag− strains of H. pylori lowers disease burden among 
the Gambian population [31]. Furthermore, coinfec-
tion with enterohepatic Helicobacter species can reduce 
H. pylori induced gastric pathology in C57BL/6 mice 
through modulation of gastric Th1 and Th17 responses 
[30]. In present study we have investigated whether cag+ 
and cag− H. pylori coinfection induces gastric mucosal 
inflammatory response differ from single strain infec-
tion. The study also focuses whether coinfection has any 
modulatory effect on gastric ulcer severity compared 
to single strain infection. We previously reported that 
both SS1 and AM1 strains were capable to cause gastric 
Fig. 5 Quantification of Foxp3+ Treg cells in H. pylori infected mouse gastric tissues. H. pylori infected and uninfected gastric tissues were stained for 
regulatory T cell marker Foxp3 and CD4. Foxp3 were stained with fluorescein isothiocyanate (FITC) (green) (Ia–Va), CD4 were stained with Texas red 
(red) (Ib–Vb), nuclei were stained with DAPI (Ic–Vc), while (Id–Vd) represent their merge pictures (a). Representative immunostaining of regulatory T 
cells for control (I), AM1/AM1 infected (II), SS1/SS1 infected (III), SS1/AM1-coinfected (IV) and AM1/SS1-coinfected (V) gastric tissues were observed 
at 40× magnification. The red arrow shows the co-localization of Foxp3 and CD4 in H. pylori-infected mouse gastric tissues (Id–Vd). Average numbers 
of FoxP3+ cells in each tissue sections were assessed from 10 different fields (1 mm2). Bar diagrams showed the average number of FoxP3+ cells 
present in different groups (b). Error bars ±SEM ***P < 0.001; **P < 0.01; *P < 0.05; NS, P = not significant versus control
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inflammation although the severity of damage was more 
pronounced in SS1 infection [26]. Although, the func-
tionality of SS1 cag gene within mouse gastric tissue is 
a controversial, but its association with severe gastric 
inflammation is well established. Our current result sug-
gested that cag+ strain (SS1) induced gastric pathology 
were significantly attenuated in mice that were earlier 
coinfected with cag− strain (AM1) and associated with 
modulation of Th17 and Treg cell responses.
It is reported that H. pylori infection is associated 
with elevated Th1 cytokines [10, 40]. Hence, we exam-
ined whether reduced gastric inflammation in AM1/SS1 
coinfected mice has any correlation with Th1 cytokines 
level. We found that despite the reduced gastric inflam-
mation pathology in AM1/SS1 infected mice, the expres-
sion of inflammatory Th1 cytokines IFN-γ, TNF-α and 
IL-1β in AM1/SS1 and SS1/AM1 are comparable (Fig. 5). 
Interestingly, significantly lower level of IL-17 was 
detected in AM1/SS1 coinfected group than SS1/AM1 
coinfected group. Previous studies established the role of 
proinflammatory Th17 pathway in the development of H. 
pylori induced gastric inflammation in mouse model and 
human [39, 41]. Yun shi et al. suggested that both Th1 and 
Th17 cells mediated mucosal inflammation is important 
in H. pylori infection and Th17/IL-17 pathway modulates 
Th1 cell responses [17]. Th17 cell responses are induced 
earlier than Th1 cell responses [17], implying that Th17 
and Th1 cells promote inflammation differentially. It is 
known that active type IV secretion system is required 
for IL-17 secretion [18]. We found that cag+ strain infec-
tion induced IL-17A secretion in mouse gastric tissues as 
well as spleen, while cag− infection did not. It seems to 
us that severe gastric inflammation in SS1/SS1 infected 
mice were mediated by both Th1 and Th17 responses 
while AM1/AM1 infection only by Th1 responses. We 
found that the level of Th1 cytokines IFN-γ, TNF-α and 
IL-1β in AM1/SS1 infected mice are comparable to SS1/
AM1infected mice. In contrast, higher level of IL-17A 
was detected in SS1/AM1 mice than AM1/SS1 infected 
mice. Thus our results clearly indicate that attenuated 
gastric pathology in AM1/SS1 infected group is not 
due to reduced Th1 responses instead of reduced Th17 
responses to AM1/SS1 infection. We conclude that the 
Th1 cytokine induced by prior AM1 infection particu-
larly IFN-γ could also contribute in part to the down-
regulation of Th17 response induced by subsequent cag+ 
(SS1) infection because IFN-γ plays an inhibitory role 
towards Th17 cell activation [42, 43]. Thus, AM1 infec-
tion released high level of IFN- γ in the gastric lumen 
that prevented the activation of Th17 response resulting 
protection against further cag+ infection.
Expression and secretion of different MMPs in H. 
pylori infection have been postulated to be critically 
involved in the development of gastric ulcer. However, 
recent evidences suggest that apart from its well stud-
ied inflammatory and pathogenic functions, MMPs play 
a more complex and diverse role in ECM homeostasis, 
regulation of inflammation, arresting disease progres-
sion [22]. Role of cytokines and growth factors in regu-
lation of MMPs expression have been reported earlier 
under various pathological conditions [22, 44]. IL-17 
stimulated gastric epithelial cells to produce MMP9 and 
3 that might be important in mediating gastric inflam-
mation. However, a significantly lower level of MMP9 
and 3 expressions were detected in AM1/SS1 coinfected 
Fig. 6 Inter-relation between Th1, Th17 and Treg cytokines in H. pylori 
infected mouse gastric tissues. Different strains of H. pylori were orally 
fed separately or in combination to C57BL/6 mice and they were sac-
rificed on day 10 postinfection. Control mice were fed with PBS and 
kept separately under same conditions. Expression of TNF-α, IL-1β, 
IL-17 and TGF-β in infected mouse gastric tissue homogenates were 
assessed by Western blotting. Representative Western blots showing 
the expression of TNF-α, IL-1β, IL-17 and TGF-β in all groups, β-actin 
served as loading control (a). Histographic representation of fold 
changes at expression level as measured by Lab Image densitometry 
values (b) from the above blots and two other representative blots 
from independent experiments in each case
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mice compared to SS1 alone or SS1/AM1 coinfected 
group (Fig.  3). In line with our observation, it has been 
reported that MMP9 expression in the stomach following 
H. pylori infection was significantly reduced when IL-17 
is deficient or blocked [17]. Moreover, recombinant IL-
17A treatment increased MMP9 expression in vitro [17]. 
Our results show that the level of IL-17 is significantly 
increased only in the mouse gastric tissues infected 
with SS1 strains of H. pylori, suggesting that cag PAI is 
required for the induction of IL-17 cytokine, and also 
indicates that the cells producing MMPs have responded 
to the increased IL-17 secretions. Our results also sug-
gested that the reduced gastritis in AM1/SS1 infected 
mice may be is due to reduced activation of Th17/IL-17 
pathway and subsequent downregulation of MMP9 and 3 
expressions in AM1/SS1 infected group.
It is well established that natural regulatory T (Foxp3+ 
Treg) cells suppress the host inflammatory responses dur-
ing infection and thereby maintain physiological homeo-
stasis of host immunity [45–47]. Elevated numbers of 
Treg cells were reported in H. pylori positive patients and 
H. pylori infected mice gastric tissues [48–50]. Moreover 
inhibition of Treg cells function by treatment with mono-
clonal antibody resulted increased expression of gastric 
proinflammatory cytokines that lead to severe gastritis 
in H. pylori infected mice [48]. CD4+CD25+ Treg cells 
from H. pylori positive patients are more potent in the 
suppression of memory T cell responses [51]. Treg medi-
ated immune suppression is predominantly utilizes IL-10 
and TGF-β that currently gain much attention [45, 46]. 
Previously it has been reported that H. pylori induced 
gastritis was suppressed by adoptive transfer of Treg cells 
harvested from IL-10-competent C57BL/6 donor mice, 
demonstrating that IL-10-dependent Treg cells play a 
crucial role in suppressing H. pylori-induced gastric dis-
ease [52]. Our results also showed that the number of 
gastric foxp3+ cells as well as gastric IL-10 and TGF-β 
level were significantly higher in H. pylori infected mouse 
gastric tissues (Figs. 5, 6). While, AM1/SS1 infected mice 
with attenuated gastritis have fewer foxp3+ cells and 
lower level of gastric IL-10 and TGF-β. Hence we found 
a positive correlation between severity of gastritis and 
no of Foxp3+  cells as well as IL-10 and TGF-β expres-
sion. Previous reports suggested that IL-10 and TGF-β 
can suppress inflammatory Th17 as well as Th1 responses 
[53, 54]. So it is reasonable to postulate that prior AM1 
infection creating an anti-inflammatory bias to further 
H. pylori infection at the outset of coinfection, with rela-
tively lower demand for Treg cells at more chronic time 
points because the Th1 and Th17 response to subsequent 
H. pylori infection was suppressed by prior AM1 primed 
Treg cells.
We hypothesized that dendritic cells exposed to H. 
pylori may promote the preferential differentiation of 
naïve T cells into Treg cells. Those exposed dendritic 
cells then assist the differentiation of Treg cells as well 
as it lost its capability to further induce Th1 and Th17 
responses upon subsequent H. pylori infection. Thus 
prior AM1 infected group showed reduced gastritis as 
its deficiency to induce Th17 response and probably 
stimulation of an anti-inflammatory bias by accumula-
tion of AM1 sensitized dendritic and Treg cells within 
the gastric mucosa. In both SS1 and AM1 infection, 
primed Treg cells generated in gastric mucosa and these 
Treg cells provide protection against further infection of 
H. pylori by either directly or through cross reactivity. 
In contrast, prior SS1 infection cause an increase in the 
level of Th1 and Th17 responses are sufficient to do gas-
tric damage. Irrespective of inhibitory role of SS1 primed 
Treg cells subsequent SS1 infection enjoy the benefit of 
existing inflammatory bias for further infection. How-
ever, earlier infection with AM1 helps in elicitation of 
AM1-primed Treg cells as well as less inflammatory bias 
through reduced secretion of Th1 cytokines. Subsequent 
infection of SS1 is prevented due to enrichment of AM1 
primed Treg cells in the gastric mucosa that might pro-
vide protection through creating an anti inflammatory 
bias as well as by providing an un-hostile environment 
due to reduced inflammatory bias.
Conclusions
In summary, we suggest that existed cag− H. pylori infec-
tion attenuated severe gastric pathology induced by cag+ 
H. pylori strain. Reduced gastric pathology is due to an 
anti-inflammatory bias created by cag− H. pylori. Further 
study is required to elucidate the cascade of interactions 
between H. pylori and mucosal cells, which will provide 
additional insights into the pathogenesis of H. pylori. A 
better understanding of the nature, regulation and func-
tion of the T-cells responses during H. pylori coinfection 
may help to design novel and cost effective strategies 
through which H. pylori induced gastric pathology might 
be controlled.
Methods
Culture of H. pylori strains
Two unrelated mouse adapted H. pylori strains with dif-
ferent genetic makeup were used: SS1 [34, 35], and AM1 
(Indian strain) [26]. SS1 (The Sydney Strain) is widely 
used as the standard mouse adapted strain for experi-
mental infection. The strain AM1 was isolated from an 
endoscopic sample of an ulcer patient in Kolkata, India 
as mixed infections [26]. Both strains of H. pylori were 
grown on brain–heart infusion agar (BHI; Difco Labora-
tories, Detroit, MI) supplemented with 7% sheep blood, 
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0.4% isovitalex and the antibiotics amphotericin B (8 µg/
ml), trimethoprim (5  µg/ml) and vancomycin (8  µg/ml) 
(referred to here as BHI agar). The plates were incubated 
at 37 °C under 5% O2, 10% CO2 and 85% N2. In all experi-
ments, overnight grown cultures on BHI agar plates were 
used.
Infection of C57BL/6 mice with H. pylori
Male C57BL/6 mice with free access to food and water 
were obtained from institutional animal house. Experi-
ments were designed to minimize animal suffering and 
to use the minimum number to obtained valid statisti-
cal evaluation. Animal experiments were carried out 
according to the guidelines of animal ethics committee of 
the institute. Animals of both control and experimental 
groups were fasted for 6  h with free access to water. H. 
pylori infection in mice was done using a modification 
of the Kundu et al. method [34]. Briefly, overnight grown 
bacterial cultures were harvested in 10  mM phosphate-
buffered saline (PBS) and used for inoculation (108 CFU/
mouse/inoculation). Mice were divided into five groups 
(n =  6 in each), first group serves as control was given 
PBS only. Among the rest 4 groups 2 groups were oro-
gastrically inoculated twice in a period of three days with 
either AM1 (cag+) or SS1 (cag−) strain (AM1/AM1 and 
SS1/SS1) and the rest 2 groups were given criss-cross 
infection. Criss–cross means infection by cag+ strain fol-
lowed by cag− and vice versa (AM1/SS1 and SS1/AM1). 
Mice were sacrificed at day 10 after final inoculation 
(13 days post-primary inoculation).
Histological analysis
Gastric tissues of control and 10-day infected mice were 
sectioned for histological studies. The tissue samples 
were fixed in 10% formalin and embedded in paraffin. 
The sections  (5  µm) were cut using microtome, stained 
with hematoxylin and eosin [21], and assessed under 
an Olympus microscope. Images were captured using 
Camedia software (E-20P 5.0 Megapixel) at original mag-
nification 10 × 10, 20 × 10 and 40 × 10 and processed in 
Adobe Photoshop version 7.0.
Tissue extraction
The pyloric part of the gastric mucosa of mice were sus-
pended in PBS containing protease inhibitors, minced 
and incubated for 10  min at 4  °C. After incubation the 
suspension was centrifuged at 12,000×g for 15 min and 
the supernatant was collected as PBS extract. The pel-
let was extracted in the lysis buffer (10  mM Tris–HCl 
pH 8.0, 150  mM NaCl, and 1% Triton X-100 and pro-
tease inhibitors) and centrifuged at 12,000×g for 15 min 
to obtain TX extracts. Tissue extracts were preserved at 
−80 °C for future studies.
Serum isolation
Blood samples were isolated from mouse by puncturing 
the heart followed by incubation for 30 min at room tem-
perature. Serum was isolated from the clotted blood by 
low centrifugation. Serum sample was mixed with pro-
tease inhibitor mixture and stored at −80 °C. Equal vol-
ume of serum was used for gelatin zymography.
Gelatin and casein zymography
For assay of MMP2, 9 and 3 activities, tissue extracts were 
electrophoresed in 8% SDS–polyacrylamide gel contain-
ing 1 mg/ml gelatin or casein (sigma) respectively, under 
non-reducing conditions. Seventy micrograms proteins 
were loaded in each lane. The gels were washed twice 
in 2.5% Triton X-100 (Sigma) and then incubated either 
in calcium assay buffer or in stromelysin assay buffer at 
37  °C. Gels were stained with 0.1% Coomassie blue fol-
lowed by destaining [21]. Quantification of zymographic-
bands were done using Lab-Image software (Kapelan, 
Gmbh, Germany).
For assay of MMP9 activity in serum, mice serum sam-
ples were mixed with 1× nonreducing Laemmli sam-
ple loading buffer and were electrophoresed in SDS-8% 
polyacrylamide gel containing 1  mg/ml gelatin under 
nonreducing condition. Equal volume of serum samples 
were loaded in each lane. The gels were washed twice in 
2.5% Triton X-100 and incubated in calcium assay buffer 
at 37  °C. Gels were then stained with 0.1% Coomas-
sie Brilliant Blue stain followed by destaining. The zone 
of gelatinolytic activities appeared as negative staining. 
Quantification of zymographic bands were performed 
by densitometric analysis using Lab Image software 
(Kapelan Gmbh, Germany).
Measurement of cytokines by ELISA
Helicobacter pylori infected and uninfected mice gastric 
tissues were homogenized in 1 ml sterile PBS, and centri-
fuged. The supernatants were analyzed for IFN-γ, IL-12, 
IL-17, IL-10 and TGF-β using sandwich ELISA kits (eBio-
science, San Diego, CA) according to the manufacturer’s 
instruction. Total protein was measured by the Lowry 
method. The cytokines concentrations in gastric tissue 
extracts were expressed as picograms per milligrams of 
total protein [17].
Splenocytes culture and cytokine measurement
Helicobacter pylori infected and uninfected mice spleens 
were passed through meshed steel sieve to obtain single-
cell suspension of splenocytes. Splenocytes (1.6  ×  106 
cells/ml) were cultured in RPMI 1640 medium with or 
without H. pylori whole cell protein (WCP) (2.5  μg/
ml).The production of IFN-γ, IL-12 and IL-17 in the 
Page 11 of 13Ghosh et al. Gut Pathog  (2017) 9:14 
supernatants was measured by sandwich ELISA (eBio-
science, San Diego, CA) after 48 h of splenocytes culture 
[17].
Immunofluoresence
For Immunofluorescence study, the tissue samples were 
fixed in 4% paraformaldehyde solution for 48  h, dehy-
drated in ascending alcohol series [36]. It was embed-
ded in paraffin wax and sectioned at 5  mm thickness 
using a microtome. The sections were deparaffinized 
with xylene followed by rehydration with descend-
ing alcohol series. Antigen retrieval was performed by 
trypsin (0.05% trypsin, 0.1% CaCl2) and blocking was 
performed using 5% BSA in TBS (20  mM Tris–HCl, 
pH 7.4 containing 150 mM NaCl) for 2 h at room tem-
perature followed by the incubation over night at 4 °C in 
primary antibody solution (1:200 dilutions in TBS with 
1% BSA) in a humid chamber. The tissue sections were 
washed four times with TBST (20 mM Tris HCl, pH 7.4 
containing 150 mM NaCl and 0.025% Triton X-100) fol-
lowed by incubation with fluorescein isothiocyanate and 
Texas Red-conjugated secondary antibody (Santa Cruz 
Biotechnology) solution. Then the tissue sections were 
washed four times with TBST followed by nuclear stain-
ing with DAPI. The images were observed in confocal 
microscopy. Images at X40 magnification were captured 
using Andor iQ 2.7 software (Andor spinning dise con-
focal microscope, Belfast, Ireland) and processed under 
Adobe Photoshop version 7.0 (Adobe Systems, San Jose, 
CA).
Western blotting
Tissue extracts (120  μg) were resolved by 10% reduc-
ing SDS–polyacrylamide gel electrophoresis and 
transferred to nitrocellulose membranes [37]. The mem-
branes were blocked for 2 h at room temperature in 3% 
bovine serum albumin solution in 20  mM Tris–HCl, 
pH 7.4 containing 150  mM NaCl and 0.02% Tween 20 
(TBST) followed by overnight incubation at 4  °C with 
1:500 polyclonal anti-MMP9 (sc-6841, Santa Cruz Bio-
technology), MMP3 (sc-6839, Santa Cruz Biotechnol-
ogy), TNF-α (sc-1351, Santa Cruz Biotechnology), IL-1β 
(sc-7884, Santa Cruz Biotechnology), IL-17 (sc-374218, 
Santa Cruz Biotechnology), TGF-β (sc-7892, Santa Cruz 
Biotechnology,) and β-actin (4967S, cell signalling tech-
nology, MA, USA) antibodies. The membranes were 
washed four times with TBST and then incubated with 
their respective alkaline phosphatase-conjugated sec-
ondary antibody (Santa Cruz Biotechnology) (1:2000) 
for 1.5  h. The bands were visualized using 5-bromo-4-
chloro-3-indolyl phosphate/nitro blue tetrazolium sub-
strate solution (Sigma).
Statistical analysis
Densitometry data are fitted using Sigma Plot. Data are 
presented as the mean ± SE. Statistical analysis was per-
formed using the Student’s t test. P value less than 0.05 
were considered as significant.
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